AngioDynamics Reports Fiscal 2018 First Quarter Results
28 sept. 2017 06h00 HE
|
AngioDynamics
Q1 net sales of $85.4 million, down 3% year-over-year Q1 GAAP earnings per share of $0.00; adjusted EPS of $0.12Q1 operating cash generation of $3.0 million; free cash flow generation of...
Outcomes in a Nurse-Led Peripherally Inserted Central Catheter Program: A Retrospective Cohort Study Published in CMAJ Open
14 sept. 2017 07h00 HE
|
AngioDynamics
Low rates of major PICC-associated complications attributed in-part to the novel BioFlo catheter material Data to be presented at AngioDynamics-sponsored symposium at the annual scientific meeting of...
AngioDynamics to Report Fiscal 2018 First Quarter Financial Results
14 sept. 2017 06h00 HE
|
AngioDynamics
ALBANY, N.Y., Sept. 14, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
13 sept. 2017 06h00 HE
|
AngioDynamics
ALBANY, N.Y., Sept. 13, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics to Present at the 2017 Morgan Stanley Global Healthcare Conference
29 août 2017 06h00 HE
|
AngioDynamics
ALBANY, N.Y., Aug. 29, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics to Present at the 2017 Canaccord Genuity Growth Conference
07 août 2017 07h48 HE
|
AngioDynamics
ALBANY, N.Y., Aug. 07, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results
18 juil. 2017 06h00 HE
|
AngioDynamics
Company posts record full-year adjusted EPS and Free Cash Flow and issues FY2018 Financial Guidance Q4 net sales of $86.9 million, down 7% year-over-yearQ4 GAAP loss per share of $0.30; adjusted EPS...
AngioDynamics to Report Fiscal 2017 Fourth Quarter and Full-Year Financial Results
07 juil. 2017 06h00 HE
|
AngioDynamics
ALBANY, N.Y., July 07, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics Announces FDA Clearance for The Solero Microwave Tissue Ablation System
07 juin 2017 06h00 HE
|
AngioDynamics
ALBANY, N.Y., June 07, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and...
AngioDynamics Lawsuit Alleges C.R. Bard is Violating Antitrust Laws, Harming Competition and Limiting Access
31 mai 2017 06h00 HE
|
AngioDynamics
ALBANY, N.Y., May 31, 2017 (GLOBE NEWSWIRE) -- C.R. Bard has illegally tied the sale of its tip location systems to its line of peripherally inserted central catheters (“PICCs”), violating federal...